All News
Filter News
Found 20,606 articles
-
Merge eMed Releases FUSION RIS(TM) And RIS/PACS Version 3.0
11/28/2005
-
PhotoMedex XTRAC(R) Receives Favorable Policy Decision From Highmark Blue Cross And Blue Shield
11/23/2005
-
GTx, Inc. To Present At The Lazard Capital Markets Annual Life Sciences Conference
11/23/2005
-
GHX And Neoforma, Inc. Announce Expiration Of Hart-Scott-Rodino Waiting Period
11/22/2005
-
Johnson & Johnson To Participate In Fifth Annual Merrill Lynch Med Tech Fundamentals Conference
11/22/2005
-
Shareholder Lawsuit Filed Against Guidant Corporation, Berman DeValerio Pease Tabacco Burt & Pucillo Says
11/21/2005
-
Synovis Life Technologies To Webcast Fiscal Fourth-Quarter And Full-Year Earnings Conference Call Wednesday, December 7
11/21/2005
-
FDA Approves Updated Labeling For GlaxoSmithKline's LEXIVA
11/18/2005
-
Millimed AB And Blue Medical Refocus Their Drug-Eluting Device Operations As Separate Stand Alone Entities
11/18/2005
-
Nuvelo, Inc. Announces Organizational Changes To Support Anticipated Growth And Future Commercialization
11/18/2005
-
Abbott Laboratories Release: New Data Show A Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated Continued Efficacy And Favorable Resistance Profile For Patients Through Seven Years Of Initial HIV Therapy
11/17/2005
-
Signet Laboratories, Inc. Announces Availability Of Polyclonal Hepsin
11/17/2005
-
Centocor, Inc. And Schering-Plough Corporation Next-Generation Biologic Shows Promise In The Treatment Of Rheumatoid Arthritis In Phase 2 Trial; Primary Endpoint Achieved
11/16/2005
-
Schering-Plough Corporation And OncoMethylome Sciences S.A. Announce License And Collaboration Agreement For Use Of OMS Pharmacogenomic Technology
11/16/2005
-
Centocor, Inc. Release: Patients With Active Psoriatic Arthritis Receiving REMICADE(R) Therapy Achieve 'Major Clinical Response' In Arthritic Component Of Disease
11/16/2005
-
Biolex Therapeutics Announces Recruitment Of Three Key Management Team Additions To Accelerate Commercialization Of Lead Programs
11/16/2005
-
Johnson & Johnson And Guidant Corporation Announce Revised Acquisition Agreement With Net Value Of $19 Billion
11/15/2005
-
Immunicon Corporation Names New CEO
11/15/2005
-
The Day In Review: Pfizer Finds A Smoking Gun
11/15/2005
-
Abbott Laboratories To Acquire License To Johnson & Johnson's Rapid Exchange Catheter Delivery Technology
11/15/2005